Ablatherm® - HIFU: A New Perspective In 2007, The Year Of The First Long Term Clinical Results On The Treatment Of Localised Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Men's health;  Clinical Trials / Drug Trials
Article Date: 13 May 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


UroToday.com - UroToday.com announced today the addition of Ablatherm® - HIFU: A New Perspective in 2007, the Year of the First Long Term Clinical Results on the Treatment of Localised Prostate Cancer to the UroToday.com HIFU (High Intensity Focused Ultrasound) Resource Center. The HIFU resource center includes all current publications, clinical information, clinical trials and media presentations related to HIFU treatment.

The clinical results are presented as follows:

Ablatherm® Long Term Results As A Salvage Option After Radiotherapy Failure By Pr. G. Conti MD, Como, Italy

Ablatherm® Efficiency on Long Term Results By F.J. Murat MD, Lyon, France

Ablatherm® Safety on Long Term Results By A. Blana MD, Regensburg, Germany

PSA Nadir: A Surrogate Marker Of Long-Term Efficacy in HIFU Therapy Localised Prostate Cancer By S. Brown MD, Stockport, UK

Visit the HIFU Resource Center and stay updated on clinical developments in HIFU and Prostate Cancer.

About UroToday UroToday.com attracts more than 45,000 readers monthly. The website covers over 22 urology disease categories and provides the most in depth Urological conference reports available online. UroToday.com is the world leader in delivering a quality, global online publication providing accurate and timely education that is clinically relevant in the practice of Urology. All scientific content is developed by urologists committed to translating research into clinically relevant science, including all genitourinary cancers, pediatric and geriatric urological dysfunctions for urologists, medical oncologists, advanced nurse practitioners and other medical professionals.

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2006 - UroToday

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Mark Brown. "Ablatherm® - HIFU: A New Perspective In 2007, The Year Of The First Long Term Clinical Results On The Treatment Of Localised Prostate Cancer." Medical News Today. MediLexicon, Intl., 13 May. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/70792.php>

APA
Mark Brown. (2007, May 13). "Ablatherm® - HIFU: A New Perspective In 2007, The Year Of The First Long Term Clinical Results On The Treatment Of Localised Prostate Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/70792.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »